Stocktoria

Minerva Neurosciences, Inc. NERV

Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2014-06-25 · LEI

Minerva Neurosciences, Inc. statistics & valuation

Market cap$203.6M
Return on capital-15.8%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Gross margin (%)
2016201720182019202020212022202320242025
Operating margin (%)
4.50% 2016201720182019202020212022202320242025
Return on equity (%)
-29.30% -24.00% -55.60% -259.80% 3.70% -625.70% 2016201720182019202020212022202320242025
Shares outstanding
35.0M 38.7M 38.9M 39.1M 42.7M 5.3M 5.3M 7.0M 7.6M 43.3M 2016201720182019202020212022202320242025
Net debt ($)
2016201720182019202020212022202320242025
Share buybacks ($)
2016201720182019202020212022202320242025
Return on assets (%)
-23.40% -17.20% -36.10% -93.10% 3.40% -64.70% -58.30% -52.70% 3.90% -299.50% 2016201720182019202020212022202320242025
Free cash flow margin (%)
2016201720182019202020212022202320242025
Debt / equity (×)
2016201720182019202020212022202320242025
EPS ($)
-$1.85 $0.05 -$9.35 -$6.01 -$4.61 $0.19 -$34.67 2016201720182019202020212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Operating margin—————4.5%————
Net margin—————4.7%————
Return on assets-299.5%3.9%-52.7%-58.3%-64.7%3.4%-93.1%-36.1%-17.2%-23.4%
Return on equity208.5%-5.6%105.4%160.3%-625.7%3.7%-259.8%-55.6%-24.0%-29.3%
Current ratio36.287.8512.5729.1522.078.687.1124.9418.948.66

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.